The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Millennium Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Millennium Pharmaceuticals opposed by its competitors

Explore Millennium Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3237004
May 8, 2024Predicting Outcome Of Treatment With An Anti- 4 7 Integrin Antibody1
EP3370729
Sep 27, 2023Methods For The Identification, Evaluation And Treatment Of Patients Having Multiple Myeloma1
EP2704742
Jul 12, 2017Formulation For Anti- 4 7 Antibody2
EP2704798
Jul 12, 2017Formulation For Anti- Alpha4Beta7 Antibody1

Latest PTAB cases involving Millennium Pharmaceuticals

Discover the latest PTAB cases involving Millennium Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Millennium Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MILLENNIUM PHARMACEUTICALS - 5 - -
DEHMEL & BETTENHAUSEN4 - - -
DR REDDYS LABORATORIES9627 -
GILL JENNINGS & EVERY18 - - -